Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Plexus
(NASDAQ:PLXS)
Intraday
$95.67
0
[0.00%]
After-Hours
$95.67
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$95.67
0
[0.00%]
At close: Apr 24
$95.67
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Q2 2024 Earnings were released on Wed Apr 24th, after the market close
Today's conference call ended over 1 hour ago
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Plexus Stock (NASDAQ:PLXS)
Plexus Stock (NASDAQ: PLXS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
Plexus Continues To Anticipate Strong Finish To FY24 With Expansion In Revenue And Non-GAAP Operating Margin Each Quarter
Benzinga Newsdesk
-
13 hours ago
Plexus Sees Q3 Revenue Of $960M-$1.00B (Est $1.022B), Adj EPS Of $1.22-$1.37 (Est $1.09)
Benzinga Newsdesk
-
13 hours ago
Plexus Q2 2024 Adj EPS $0.58 Misses $0.87 Estimate, Sales $967.000M Beat $950.832M Estimate
Benzinga Newsdesk
-
13 hours ago
Friday, March 08, 2024
In-Depth Examination Of 5 Analyst Recommendations For Plexus
Benzinga Insights
-
Mar 8, 2024, 2:00PM
Benchmark Reiterates Buy on Plexus, Maintains $110 Price Target
Benzinga Newsdesk
-
Mar 8, 2024, 12:47PM
Tuesday, February 13, 2024
Shares of several companies in the broader tech sector are trading lower as Treasury yields rise following a greater-than-expected increase in U.S. January inflation data.
Benzinga Newsdesk
-
Feb 13, 2024, 3:32PM
Thursday, January 25, 2024
Needham Maintains Buy on Plexus, Lowers Price Target to $107
Benzinga Newsdesk
-
Jan 25, 2024, 3:21PM
Wednesday, January 24, 2024
Plexus Sees Q2 2024 GAAP EPS $0.48-$0.63; Revenue $930M-970M VS $1.01B Est.
Benzinga Newsdesk
-
Jan 24, 2024, 4:25PM
Recap: Plexus Q1 Earnings
Benzinga Insights
-
Jan 24, 2024, 4:25PM
Plexus Q1 2024 GAAP EPS $1.04, Inline, Sales $983.00M Miss $987.63M Estimate
Benzinga Newsdesk
-
Jan 24, 2024, 4:22PM
Earnings Scheduled For January 24, 2024
Benzinga Insights
-
Jan 24, 2024, 5:11AM
Tuesday, January 23, 2024
A Preview Of Plexus's Earnings
Benzinga Insights
-
Jan 23, 2024, 1:01PM
Thursday, January 18, 2024
Demystifying Plexus: Insights From 4 Analyst Reviews
Benzinga Insights
-
Jan 18, 2024, 2:00PM
Needham Maintains Buy on Plexus, Lowers Price Target to $110
Benzinga Newsdesk
-
Jan 18, 2024, 1:50PM
Wednesday, January 17, 2024
Plexus shares are trading lower after the company said it will not meet its Q1 revenue guidance, GAAP operating margin and GAAP EPS guidance.
Benzinga Newsdesk
-
Jan 17, 2024, 10:43AM
Benchmark Reiterates Buy on Plexus, Maintains $110 Price Target
Benzinga Newsdesk
-
Jan 17, 2024, 10:24AM
Tuesday, January 16, 2024
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Jan 16, 2024, 4:30PM
Plexus Board Approves New $50M Share Repurchase Program
Benzinga Newsdesk
-
Jan 16, 2024, 4:21PM
Plexus Says It Will Not Meet Its Q1 Revenue Guidance Of $990M-$1.03B, Will Not Meet Its Operating Margin And GAAP EPS Guidance
Benzinga Newsdesk
-
Jan 16, 2024, 4:20PM
Tuesday, January 09, 2024
Sidoti & Co. Downgrades Plexus to Neutral, Announces $112 Price Target
Benzinga Newsdesk
-
Jan 9, 2024, 10:05AM
Wednesday, December 20, 2023
On December 19, 2023, Plexus Corp. Learned That The U.S. Department Of Commerce Placed Its Xiamen, China Subsidiary On The Bureau Of Industry And Security's Unverified List.
Benzinga Newsdesk
-
Dec 20, 2023, 9:27AM
Friday, October 27, 2023
Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday
Lisa Levin
-
Oct 27, 2023, 8:06AM
Needham Maintains Buy on Plexus, Raises Price Target to $113
Benzinga Newsdesk
-
Oct 27, 2023, 7:01AM
Thursday, October 26, 2023
Plexus shares are trading higher after the company reported Q4 financial results and issued Q1 revenue guidance.
Benzinga Newsdesk
-
Oct 26, 2023, 11:37AM
Wednesday, October 25, 2023
Plexus Corp Sees Q1 2024 Revenue $990M-$1.03B Vs $1.03B Est
Benzinga Newsdesk
-
Oct 25, 2023, 4:33PM
Plexus Corp Q4 EPS $1.44 Down From $1.78 YoY, Revenue $1.02B Misses $1.019 Estimate
Benzinga Newsdesk
-
Oct 25, 2023, 4:30PM
Earnings Scheduled For October 25, 2023
Benzinga Insights
-
Oct 25, 2023, 7:32AM
Friday, July 28, 2023
Plexus' Strength In Commercial Aerospace To Outweigh Demand Issues In Industrial And Healthcare Life Science Market: Analyst
Nabaparna Bhattacharya
-
Jul 28, 2023, 2:21PM
Needham Maintains Buy on Plexus, Raises Price Target to $107
Benzinga Newsdesk
-
Jul 28, 2023, 6:59AM
Wednesday, July 26, 2023
Plexus Q3 Adj $1.32 Beats $1.02 Estimate, Sales $1.02B Inline
Benzinga Newsdesk
-
Jul 26, 2023, 4:44PM
Earnings Scheduled For July 26, 2023
Benzinga Insights
-
Jul 26, 2023, 4:18AM
Friday, April 28, 2023
Needham Maintains Buy on Plexus, Lowers Price Target to $105
Benzinga Newsdesk
-
Apr 28, 2023, 6:09AM
Thursday, April 27, 2023
Looking Into Plexus's Return On Invested Capital
Benzinga Insights
-
Apr 27, 2023, 10:50AM
Wednesday, April 26, 2023
Plexus Sees Q3 Revenue $1.00B-$1.05B Vs $1.08B Est.
Michael Horton
-
Apr 26, 2023, 4:06PM
Plexus Q2 EPS $1.45 Beats $1.15 Estimate, Sales $1.07B Beat $1.05B Estimate
Michael Horton
-
Apr 26, 2023, 4:04PM
Earnings Scheduled For April 26, 2023
Benzinga Insights
-
Apr 26, 2023, 7:13AM
Tuesday, January 31, 2023
Top 5 Tech Stocks That May Rally
Lisa Levin
-
Jan 31, 2023, 7:17AM
Friday, January 27, 2023
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
Benzinga Insights
-
Jan 27, 2023, 10:00AM
4 Analysts Have This to Say About Plexus
Benzinga Insights
-
Jan 27, 2023, 10:00AM
Sidoti & Co. Upgrades Plexus to Buy, Announces $116 Price Target
Benzinga Newsdesk
-
Jan 27, 2023, 9:46AM
JP Morgan Maintains Underweight on Plexus, Lowers Price Target to $86
Benzinga Newsdesk
-
Jan 27, 2023, 8:58AM
Needham Maintains Buy on Plexus, Lowers Price Target to $108
Benzinga Newsdesk
-
Jan 27, 2023, 6:45AM
Thursday, January 26, 2023
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Jan 26, 2023, 1:28PM
12 Information Technology Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jan 26, 2023, 12:30PM
Plexus shares are trading lower after the company reported worse-than-expected Q1 sales results and issued Q2 EPS and revenue guidance below estimates.
Benzinga Newsdesk
-
Jan 26, 2023, 10:37AM
Wednesday, January 25, 2023
Plexus Sees Q2 Revenue $1.02B-$1.07B Vs $1.1B Est., EPS $1.06-$1.24 Vs $1.40 Est.
Michael Horton
-
Jan 25, 2023, 4:19PM
Plexus Q1 EPS $1.49 Beats $1.48 Estimate, Sales $1.09B Miss $1.11B Estimate
Michael Horton
-
Jan 25, 2023, 4:17PM
Earnings Scheduled For January 25, 2023
Benzinga Insights
-
Jan 25, 2023, 4:30AM
Tuesday, January 24, 2023
Earnings Outlook For Plexus
Benzinga Insights
-
Jan 24, 2023, 12:01PM
Tuesday, January 17, 2023
Sidoti & Co. Downgrades Plexus to Neutral, Announces $116 Price Target
Benzinga Newsdesk
-
Jan 17, 2023, 10:02AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch